CERTIFICATE OF ANALYSIS |
Drug Name: Framycetin sulfate |
Report No. | 2105001 | MFG Date | May,30,2021 |
Batch No. | 2105001 | Date of Release | May,30,2021 |
Batch Size | 100kgs | Expriation Date | April,30,2023 |
Test | Specification | Result |
Characters | A white or yellowish-white hydroscopic powder, very soluble in water, very slightly soluble in alcohol,practically insoluble in acetone. | white powder |
Identification | (A) The retention time of a major peak meets the requirements (B) Impurity C meets the requirements ≤3.0% C: identification of sulfate:it gives reacetion of sulphate | (A) Complies (B) 1.94% (C)complies |
PH | 6.0-7.0 | 6.5 |
Specific optical rotation | +52.5°-+55.5° | +54.0° |
Related substances | Impurity A(Neamine):NMT 1.00% | 0.02% |
Impurity C:NMT 3.0% | 1.94% |
Total of other impurities:NMT 3.0% | 0.33% |
Sulphate(anhydrous) | 27.0%-31.0% | 29.20% |
Loss on drying | NMT 8.0% | 4.8% |
Sulphate ash | NMT 1.0% | <0.3% |
Bacterial endotoxin | less than 0.8 IU/mg | <0.8EU/mg |
Potency | NLT 630IU/mg (dries substance) | 640U/mg (dried substance) |
|
Conclusion: Complies with EP9.0 |